Eli Lilly and Company's (NYSE:LLY) large institutional owners must be happy as stock continues to impress, up 4.7% over the ...

We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...

Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In an era where financial literacy is increasingly recognized as a crucial ...

Good morning, thank you for joining us for Eli Lilly and Company's Q4 2024 earnings call ... and announced a new Lilly Gateway lab in the UK to collaborate with European research.

Eli Lilly is not only a great investment, it is a company at the forefront of catalyzing making America healthy again. Mounjaro and Zepbound (the company's blockbuster weight-loss drugs ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Eli Lilly And Co. (LLY) reported earnings for its fourth quarter that increased from last year and beat the Street estimates. The ...